Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials

<strong>Purpose: </strong>To explore which microperimetry sensitivity index (pointwise sensitivity, mean sensitivity, and volume sensitivity) is suitable as a microperimetry outcome measure in patients with X-linked RPGR-associated retinitis pigmentosa (RP). <br><strong> Meth...

Full description

Bibliographic Details
Main Authors: Taylor, LJ, Josan, AS, Jolly, JK, MacLaren, RE
Format: Journal article
Language:English
Published: Association for Research in Vision and Ophthalmology 2023
_version_ 1797110892223004672
author Taylor, LJ
Josan, AS
Jolly, JK
MacLaren, RE
author_facet Taylor, LJ
Josan, AS
Jolly, JK
MacLaren, RE
author_sort Taylor, LJ
collection OXFORD
description <strong>Purpose: </strong>To explore which microperimetry sensitivity index (pointwise sensitivity, mean sensitivity, and volume sensitivity) is suitable as a microperimetry outcome measure in patients with X-linked RPGR-associated retinitis pigmentosa (RP). <br><strong> Methods: </strong>Microperimetry data from patients with RPGR-associated RP were collected and analyzed retrospectively. Fourteen participants completed triplicate microperimetry testing, across 2 consecutive days for the repeatability analyses. Longitudinal data was obtained from 13 participants who completed microperimetry testing at two separate visits. <br><strong> Results: </strong>The test–retest coefficients of repeatability (CoR) for pointwise sensitivity were ±9.5 dB and ±9.3 dB, in the right and left eyes, respectively. The mean sensitivity CoR for the right and left eyes was ±0.7 dB and ±1.3 dB. Volume sensitivity CoR was ±144.5 dB*deg2 and ±324.2 dB*deg2 for the right and left eyes, respectively. The mean sensitivities were positively skewed toward zero in those with a high number of nonseeing points (arbitrarily assigned to −1.0 dB) and just seen points (0.0 dB). Volume sensitivities were unaffected by the averaging effects of skewed data. <br><strong> Conclusions: </strong>Clinical trials should report population-specific test–retest variability to determine a clinically significant change. Pointwise sensitivity indices should be used with caution as outcome measures in clinical trials owing to high levels of test–retest variability. Global indices seem to be less prone to variability. Volume sensitivity indices seem to be superior for use in RPGR-associated RP clinical trials compared with mean sensitivity because they are unaffected by the averaging effects of highly skewed data. <br><strong> Translational Relevance: </strong>Careful selection of sensitivity indices (VA) is required when using microperimetry as a clinical trial outcome measure.
first_indexed 2024-03-07T08:01:04Z
format Journal article
id oxford-uuid:cd5f0991-ea8c-4fd5-b85a-349487b6aee0
institution University of Oxford
language English
last_indexed 2024-03-07T08:01:04Z
publishDate 2023
publisher Association for Research in Vision and Ophthalmology
record_format dspace
spelling oxford-uuid:cd5f0991-ea8c-4fd5-b85a-349487b6aee02023-09-20T11:07:59ZMicroperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:cd5f0991-ea8c-4fd5-b85a-349487b6aee0EnglishSymplectic ElementsAssociation for Research in Vision and Ophthalmology2023Taylor, LJJosan, ASJolly, JKMacLaren, RE<strong>Purpose: </strong>To explore which microperimetry sensitivity index (pointwise sensitivity, mean sensitivity, and volume sensitivity) is suitable as a microperimetry outcome measure in patients with X-linked RPGR-associated retinitis pigmentosa (RP). <br><strong> Methods: </strong>Microperimetry data from patients with RPGR-associated RP were collected and analyzed retrospectively. Fourteen participants completed triplicate microperimetry testing, across 2 consecutive days for the repeatability analyses. Longitudinal data was obtained from 13 participants who completed microperimetry testing at two separate visits. <br><strong> Results: </strong>The test–retest coefficients of repeatability (CoR) for pointwise sensitivity were ±9.5 dB and ±9.3 dB, in the right and left eyes, respectively. The mean sensitivity CoR for the right and left eyes was ±0.7 dB and ±1.3 dB. Volume sensitivity CoR was ±144.5 dB*deg2 and ±324.2 dB*deg2 for the right and left eyes, respectively. The mean sensitivities were positively skewed toward zero in those with a high number of nonseeing points (arbitrarily assigned to −1.0 dB) and just seen points (0.0 dB). Volume sensitivities were unaffected by the averaging effects of skewed data. <br><strong> Conclusions: </strong>Clinical trials should report population-specific test–retest variability to determine a clinically significant change. Pointwise sensitivity indices should be used with caution as outcome measures in clinical trials owing to high levels of test–retest variability. Global indices seem to be less prone to variability. Volume sensitivity indices seem to be superior for use in RPGR-associated RP clinical trials compared with mean sensitivity because they are unaffected by the averaging effects of highly skewed data. <br><strong> Translational Relevance: </strong>Careful selection of sensitivity indices (VA) is required when using microperimetry as a clinical trial outcome measure.
spellingShingle Taylor, LJ
Josan, AS
Jolly, JK
MacLaren, RE
Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
title Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
title_full Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
title_fullStr Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
title_full_unstemmed Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
title_short Microperimetry as an outcome measure in RPGR-associated retinitis pigmentosa clinical trials
title_sort microperimetry as an outcome measure in rpgr associated retinitis pigmentosa clinical trials
work_keys_str_mv AT taylorlj microperimetryasanoutcomemeasureinrpgrassociatedretinitispigmentosaclinicaltrials
AT josanas microperimetryasanoutcomemeasureinrpgrassociatedretinitispigmentosaclinicaltrials
AT jollyjk microperimetryasanoutcomemeasureinrpgrassociatedretinitispigmentosaclinicaltrials
AT maclarenre microperimetryasanoutcomemeasureinrpgrassociatedretinitispigmentosaclinicaltrials